The ALT-SPF consortium, initiated by DSM Nutritional Products AG and Sun Protection Facilitator GmbH, aims to evaluate, characterize and compare alternative testing methods to current gold standard in vivo testing method ISO 24444:2019 for sun protection factors and to publish the results obtained in peer-reviewed journal(s). A call for expression of interest to participate has been launched on the ALT-SPF website, with a call deadline on 3 August 2020.

The SPF procedure as described in ISO 24444:2019 and the quite comparable procedure in the US as defined by the FDA for SPF measurement are labor-intensive and complex human tests. The UV challenge to the subjects is on a small area but can bear considerable dosages, which is why there has long been a desire for alternative methods. Moreover, the complexity of the procedure and some intrinsic variabilities of this biological test (human subjects, human sunscreen application and human readout) create, for validation purposes, a relatively large random variability, in particular, between different laboratories performing these tests.

Skin cancer incidence rates are still growing around the globe and there are not many silver streams on the horizon that this trend diminishes. The SPF value, measured on human skin, represents a number that is intrinsically linked with the protection against DNA damage in human skin and thus it is connected with the protective ability of sunscreens against skin cancer, although, application of sunscreens should not be the only strategy against the disease. An alternative SPF test method should therefore deliver at least equivalent results as the current SPF in vivo in terms of accuracy and there is on top the desire, that the new method shows improvements in precision (repeatability and reproducibility), is easy to adapt by laboratories and cost-effective to perform.

Over the last two to three decades alternative methods such as for example, in vitro transmission tests in silico calculation, or non-invasive in vivo testing (using negligible UV dose on humans) have emerged and been developed to a stage that makes them promising alternatives.

The desire to understand the precision behavior of the alternative methods demand sophisticated statistical tools to analyze and, in particular, to characterize them for a general public use. These statistical tools aim to deliver key features to rate accuracy and to measure reproducibility, degree of systematic errors against different categories of sunscreens. The accuracy, repeatability and reproducibility should be known to decide on the release of a method measuring protective abilities of sunscreens that are linked to skin cancer prevention.

Comparing alternative SPF data against the gold standard requires a solid set of in vivo SPF data and thus represents a significant experimental effort that should not be repeated for each alternative method. This is how, in 2018, the main idea for the ALT-SPF project was born.

Who should participate?

This call for interest has for aim to invite the following interested parties to express their interest to join the consortium:

(i) any interested organization active in the manufacturing of sunscreens or UV filters; and/or

(ii) any interested organization active in alternative methods development to ISO 24444:2019 that fulfills the following cumulative criteria: 

  • be able to provide scientific evidence that the alternative method shows agreement with SPF in vivo (ideally according to ISO 24444); and
  • willing to carry the efforts to provide test data and costs for individual statistical analysis and reporting, if required; and
  • be able to provide adequate number of laboratories to test, using the alternative method, the agreed number of sunscreen samples, following the agreed statistical approach (instructions to be agreed by consortium members after the call closure).

To find out more, please visit www.alt-spf.com

Zurück nach oben
Cookies erleichtern die Bereitstellung unserer Dienste. Mit der Nutzung unserer Dienste erklären Sie sich damit einverstanden, dass wir Cookies verwenden.
Weitere Informationen Ok